BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, April 30, 2026
Home » Authors » Nuala Moran

Articles by Nuala Moran

NCI Begins Exploratory Cancer Trials With Xenova's Tariquidar

March 3, 2004
By Nuala Moran

University Of Glasgow, Pharmetix Join Together To Start Grannus

Feb. 25, 2004
By Nuala Moran

Domantis Plans dAbs Trials With £17.5M In Second-Round Funds

Feb. 25, 2004
By Nuala Moran

Domantis Plans dAbs Trials With £17.5M In Second-Round Funds

Feb. 25, 2004
By Nuala Moran

University Of Glasgow, Pharmetix Join Together To Start Grannus

Feb. 25, 2004
By Nuala Moran

GeneMedix Considers Merger, Plans U.S. Listing On Nasdaq

Feb. 18, 2004
By Nuala Moran

Ark To Test London's IPO Waters With £55M Offering

Feb. 18, 2004
By Nuala Moran
LONDON - Ark Therapeutics Group Ltd. has confirmed plans for an initial public offering to raise £55 million (US$104.7 million), a move that will be followed closely by those at cash-starved companies across Europe who are waiting for the IPO window to open. (BioWorld International)
Read More

Ark To Test London's IPO Waters With £55M Offering

Feb. 18, 2004
By Nuala Moran
LONDON - Ark Therapeutics Group Ltd. has confirmed plans for an initial public offering to raise £55 million (US$104.7 million), a move that will be followed closely by those at cash-starved companies across Europe who are waiting for the IPO window to open. (BioWorld International)
Read More

GeneMedix Considers Merger, Plans U.S. Listing On Nasdaq

Feb. 18, 2004
By Nuala Moran

Ark Seeks Listing On London Stock Exchange Via £50 IPO

Feb. 11, 2004
By Nuala Moran
LONDON - Ark Therapeutics Group plc is feeling out investor appetite for what would be the first listing of a biotechnology company on the main market of the London Stock Exchange in three years. (BioWorld International)
Read More
Previous 1 2 … 459 460 461 462 463 464 465 466 467 … 536 537 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 29, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 28, 2026
  • Chinabio 2026 partnering

    Chinese biotechs gain leverage as partners in dealmaking

    BioWorld
    China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
  • Roche identifies new TREM2 agonists

    BioWorld Science
    F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
  • Silhouette of head, brain

    Plasticity, properly parsed, provides psychiatric platform

    BioWorld
    If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing